Data compiled by Redley Lamar · ChainSifter Intelligence
10Suppliers
7Customers
2Debt Items
20Related Chains
Source-Backed Evidence Depth
Tango Therapeutics, Inc. (TNGX) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
20Total relationships
2Distinct source URLs
9High confidence
0.772Average confidence
2026-09-13Latest database update
ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.
Tango Therapeutics, Inc. Suppliers
Ticker
Name
Confidence
Evidence
WUXI-APPTEC
WUXI-APPTEC
92%
an affiliate of WuXi AppTec is the sole source of API for all of our clinical-stage product candidates
ERASCA
ERASCA
90%
Erasca is supplying ERAS-0015 at no cost.
CLINICAL-SUPPLY-MANUFACTURING-VENDORS
CLINICAL-SUPPLY-MANUFACTURING-VENDORS
80%
The Company enters into contracts in the normal course of business with other vendors for clinical supply manufacturing or other preclinical and clinical services.
CONTRACT-RESEARCH-ORGANIZATIONS
CONTRACT-RESEARCH-ORGANIZATIONS
80%
The Company enters into certain agreements with contract research organizations in the ordinary course of business that contain indemnification provisions.
PROFESSIONAL-CONSULTANTS
PROFESSIONAL-CONSULTANTS
80%
The Company enters into contracts in the normal course of business with professional consultants for expert advice.
BUSINESS-PARTNERS
BUSINESS-PARTNERS
70%
The Company enters into certain agreements with business partners in the ordinary course of business that contain indemnification provisions.
CLINICAL-TRIAL-SITES
CLINICAL-TRIAL-SITES
70%
The Company enters into certain agreements with clinical trial sites in the ordinary course of business that contain indemnification provisions.
CONSTRUCTION-COMPANIES
CONSTRUCTION-COMPANIES
70%
The Company enters into certain agreements with construction companies in the ordinary course of business that contain indemnification provisions.
DIRECTORS-AND-OFFICERS
DIRECTORS-AND-OFFICERS
70%
The Company enters into certain agreements with directors and officers in the ordinary course of business that contain indemnification provisions.
LANDLORDS
LANDLORDS
70%
The Company enters into certain agreements with landlords in the ordinary course of business that contain indemnification provisions.
Tango Therapeutics, Inc. Customers
Ticker
Name
Confidence
Evidence
GILEAD
GILEAD
90%
The Company identified a single combined performance obligation under the Gilead Agreement consisting of the research services and continued participation on the joint steering committee during the r…
Reciprocal relationship from GILD graph: Reciprocal relationship from TNGX graph: of $100.0 million of shares of its common stock through Leerink, as sales agent. Sales of the common stock, if any, w…
of $100.0 million of shares of its common stock through Leerink, as sales agent. Sales of the common stock, if any, will be made by methods deemed to be "at-the-market" stock offerings. The Leerink S…
Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections 98 PART III Item 10. Directors, Executive Officers and Corporate Governance 100 Item 11. Executive Compensation 100 Item 1…
LEERINK-PARTNERS-LLC
LEERINK-PARTNERS-LLC
62%
e, investor and public relations activities and other expenses associated with operating as a public company. Our net losses may fluctuate significantly from quarter-to-quarter and year-to-year, depe…
SESAME-THERAPEUTICS-INC
SESAME-THERAPEUTICS-INC
62%
,787 $ 6,267 $ 5,526 Variable lease cost 2,977 3,268 3,815 Sublease Income ( 117 ) ( 1,495 ) ( 1,467 ) Total operating lease costs $ 9,647 $ 8,040 $ 7,874 Other information December 31, 2025 December…
Tango Therapeutics, Inc. Debt Obligations
Instrument
Description
Confidence
Evidence
TNGX-DEBT
Debt stack $32.8M
90%
Market cache reports total debt of $32.8M.
TNGX-DEBT-13038
Xbrl Convertible
90%
xbrl convertible detail from xbrl 2021-06-30.
Tango Therapeutics, Inc. Acquisitions
No acquisitions on recordNo completed or pending acquisitions found in our database for Tango Therapeutics, Inc..
Tango Therapeutics, Inc. Ownership
Holder
Name
Confidence
Evidence
TNGX-OWNER-WOODLINE-PARTNERS-LP
Woodline Partners LP
90%
13F overlay lists Woodline Partners LP as top holder; 196 tracked holders.
Tango Therapeutics, Inc. Extended Supply Chain Network
